Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 10:16 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 265–288 of 785 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Gene Expression Clear all

Conditions: Pulmonary Fibrosis
Interventions: Not listed
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2030
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Chronic Bronchitis
Interventions: Salmeterol or Salmeterol/Fluticasone; Drug
Lead sponsor: National Jewish Health; Other
Eligibility: 40 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Liver Cancer
Interventions: Not listed
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2008
U.S. locations: 1
States / cities: Stanford, California

Conditions: Non-small Cell Lung Cancer Metastatic, Non-small Cell Lung Cancer Stage IIIB
Interventions: Avelumab, Axitinib, Palbociclib; Drug
Lead sponsor: Worldwide Innovative Network Association; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 2
States / cities: La Jolla, California • Sioux Falls, South Dakota

Conditions: Non Small Cell Lung Cancer
Interventions: Pegilodecakin, Pembrolizumab; Biological · Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 74
States / cities: Huntsville, Alabama • Tempe, Arizona • Beverly Hills, California + 66 more

Conditions: Healthy Men, Healthy Women
Interventions: Control, Garlic treatment; Other
Lead sponsor: USDA Beltsville Human Nutrition Research Center; Federal
Eligibility: 40 Years to 80 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Beltsville, Maryland

Conditions: Breast Cancer
Interventions: trastuzumab (Herceptin®); Drug
Lead sponsor: University of Michigan Rogel Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Musculoskeletal Pain
Interventions: Emotional Awareness and Expression Therapy; Behavioral
Lead sponsor: VA Greater Los Angeles Healthcare System; Federal
Eligibility: 60 Years to 95 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Kidney Transplant Recipients
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 499 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 4
States / cities: Phoenix, Arizona • Jacksonville, Florida • Detroit, Michigan + 1 more

Conditions: Physical Function, Vitamin D Insufficiency
Interventions: calcium, Vitamin D plus calcium; Dietary Supplement
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 70 Years to 89 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Healthy, Obesity
Interventions: Adipose Biopsy, Blood sample, CT Scan, DEXA; Procedure · Radiation
Lead sponsor: University of California, San Diego; Other
Eligibility: 20 Years to 35 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Cancer
Interventions: protein expression analysis, immunohistochemistry staining method, laboratory biomarker analysis, biopsy; Genetic · Other · Procedure
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: Up to 120 Years
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Breast Cancer
Interventions: Taxotere; Drug
Lead sponsor: Baylor Breast Care Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2005
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Chest Pain, Coronary Artery Disease, Cardiovascular Diseases, Coronary Heart Disease, Angina Pectoris, CAD, CVD, CHD
Interventions: CORUS CAD (ASGES); Diagnostic Test
Lead sponsor: CardioDx; Industry
Eligibility: 18 Years and older
Enrollment: 713 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 13
States / cities: Chandler, Arizona • Hiawassee, Georgia • Suwanee, Georgia + 10 more

Conditions: Obesity, Inflammation, Nutrition Therapy
Interventions: Not listed
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 25 Years to 45 Years
Enrollment: 144 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2018
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: COPD
Interventions: Bronchoscopy; Procedure
Lead sponsor: University of Virginia; Other
Eligibility: 40 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Breast Cancer
Interventions: laboratory biomarker analysis, therapeutic dietary intervention; Other · Procedure
Lead sponsor: Brabant Research; Industry
Eligibility: 18 Years to 70 Years · Female only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Spokane Valley, Washington

Conditions: Morbid Obesity
Interventions: Bariatric surgery.; Procedure
Lead sponsor: University of California, Los Angeles; Other
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 2
States / cities: Los Angeles, California

Conditions: Gaucher's Disease
Interventions: human glucocerebrosidase cDNA; Genetic
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: Not listed
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1988 – 2002
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Breast Cancer
Interventions: laboratory biomarker analysis; Other
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: Female only
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2011
U.S. locations: 3
States / cities: Sioux City, Iowa

Conditions: Dry Eye
Interventions: intense pulsed light; Device
Lead sponsor: Toyos Clinic; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Atopic Dermatitis, Psoriasis
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 70 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2009
U.S. locations: 2
States / cities: San Diego, California • Denver, Colorado

Conditions: Sickle Cell Disease
Interventions: Oxypurinol, L-NMMA, Acetylcholine; Drug
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Atopic Dermatitis, Eczema, Food Allergy
Interventions: Evaluating atopy in infants, Evaluating TEWL and STS in adults; Other
Lead sponsor: National Jewish Health; Other
Eligibility: 34 Weeks to 50 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Denver, Colorado

Search by objective public record fields.

Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF)

Evaluating Genes in Sputum to Measure Drug Response in COPD

Microarray Analysis of Gene Expression in Liver Tumors

Survival Prolongation by Rationale Innovative Genomics

Study of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer

Garlic Intake And Biomarkers Of Cancer Risk

Use of Trastuzumab to Induce Increased ER Expression in ER-negative/Low, Her-2/Neu Positive Breast Cancer

vEAET for Older Veterans With Chronic Musculoskeletal Pain Pilot

Validation of Gene Expression Markers of Renal Allograft Functional Decline

Vitamin D Supplementation and Physical Function in Older Adults

Sex Differences in Gene Expression in Human Adipose Tissue

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer

A Registry to Evaluate Patterns of Care Associated With the Use of Corus CAD (or ASGES) in Primary Care Settings

Gene Expression and Inflammation in Overweight Subjects

Interleukin-5 Receptor Expression in COPD

Plant Extracted Natural Compounds Impact on Stage IV Breast Cancer Survival Time and Remission.

Bariatric Surgery Outcomes

Gene Therapy for Gaucher's and Fabry Disease Using Viruses and Blood-Forming Cells

Gene Expression Profiling and Genetic Analysis of Tissues From Patients With Breast Cancer

Intense Pulse Light Treatment With Meibomian Gland Expression of the Upper Eyelids in Dry Eye Disease

Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and Psoriasis

Atorvastatin Therapy to Improve Endothelial Function in Sickle Cell Disease

Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy